phosphoserine has been researched along with Akinetic-Rigid Variant of Huntington Disease in 5 studies
Phosphoserine: The phosphoric acid ester of serine.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (40.00) | 29.6817 |
| 2010's | 2 (40.00) | 24.3611 |
| 2020's | 1 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Martín-Flores, N | 1 |
| Pérez-Sisqués, L | 1 |
| Creus-Muncunill, J | 1 |
| Masana, M | 1 |
| Ginés, S | 2 |
| Alberch, J | 1 |
| Pérez-Navarro, E | 1 |
| Malagelada, C | 1 |
| Daldin, M | 1 |
| Fodale, V | 1 |
| Cariulo, C | 1 |
| Azzollini, L | 1 |
| Verani, M | 1 |
| Martufi, P | 1 |
| Spiezia, MC | 1 |
| Deguire, SM | 1 |
| Cherubini, M | 1 |
| Macdonald, D | 1 |
| Weiss, A | 1 |
| Bresciani, A | 1 |
| Vonsattel, JG | 1 |
| Petricca, L | 1 |
| Marsh, JL | 1 |
| Santimone, I | 1 |
| Marano, M | 1 |
| Lashuel, HA | 1 |
| Squitieri, F | 1 |
| Caricasole, A | 1 |
| Roe, AJ | 1 |
| Qi, X | 1 |
| Pineda, JR | 1 |
| Pardo, R | 1 |
| Zala, D | 1 |
| Yu, H | 1 |
| Humbert, S | 2 |
| Saudou, F | 2 |
1 review available for phosphoserine and Akinetic-Rigid Variant of Huntington Disease
| Article | Year |
|---|---|
[Huntington's disease: intracellular signaling pathways and neuronal death].
Topics: Animals; Apoptosis; Apoptosis Regulatory Proteins; Axonal Transport; Brain-Derived Neurotrophic Fact | 2005 |
4 other studies available for phosphoserine and Akinetic-Rigid Variant of Huntington Disease
| Article | Year |
|---|---|
Synaptic RTP801 contributes to motor-learning dysfunction in Huntington's disease.
Topics: Adaptor Proteins, Signal Transducing; Animals; Cells, Cultured; Cerebral Cortex; Corpus Striatum; De | 2020 |
Polyglutamine expansion affects huntingtin conformation in multiple Huntington's disease models.
Topics: Animals; Brain; Disease Models, Animal; Drosophila; Exons; Fibroblasts; HEK293 Cells; Humans; Huntin | 2017 |
Drp1 phosphorylation by MAPK1 causes mitochondrial dysfunction in cell culture model of Huntington's disease.
Topics: Animals; Butadienes; Corpus Striatum; Dynamins; GTP Phosphohydrolases; Huntington Disease; Membrane | 2018 |
Genetic and pharmacological inhibition of calcineurin corrects the BDNF transport defect in Huntington's disease.
Topics: Animals; Biological Transport; Brain-Derived Neurotrophic Factor; Calcineurin; Calcineurin Inhibitor | 2009 |